IGF2BP2 levels can also use as a prognostic indicator of acute myelocytic leukemia 25, breast cancer 53, endometrial adenocarcinoma 54, liposarcoma 55, pancreatic cancer 27, hepatocellular carcinoma 30 and OSCC 35. The gene discussed is IGF2BP2; the disease is breast carcinoma.